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Introduction. Despite widespread and liberal use of oxygen supplementation, guidelines about rational use of oxygen are scarce.
Recent data demonstrates that current protocols lead to hyperoxemia in the majority of the patients and most health care
professionals are not aware of the negative effects of hyperoxemia. Method. To investigate the effects of hyperoxemia in acutely
ill patients on clinically relevant outcomes, such as neurological and functional status as well as mortality, we performed a literature
review usingMedline (PubMed) and Embase.We used the following terms: hyperoxemia OR hyperoxemia OR [“oxygen inhalation
therapy” AND (mortality OR death OR outcome OR survival)] OR [oxygen AND (mortality OR death OR outcome OR survival)].
Original studies about the clinical effects of hyperoxemia in adult patients suffering fromacute or emergency illnesseswere included.
Results. 37 articles were included, of which 31 could be divided into four large groups: cardiac arrest, traumatic brain injury (TBI),
stroke, and sepsis. Although a single study demonstrated a transient protective effect of hyperoxemia after TBI, other studies
revealed higher mortality rates after cardiac arrest, stroke, and TBI treated with oxygen supplementation leading to hyperoxemia.
Approximately half of the studies showed no association between hyperoxemia and clinically relevant outcomes.Conclusion. Liberal
oxygen therapy leads to hyperoxemia in a majority of patients and hyperoxemia may negatively affect survival after acute illness.
As a clinical consequence, aiming for normoxemia may limit negative effects of hyperoxemia in patients with acute illness.
1. Introduction
Oxygen is a vital element and toxicitymay not be immediately
obvious. Moreover, impaired oxygen delivery in critically ill
patients is associated with increased mortality. As a conse-
quence, reassuring oxygen delivery has become a cornerstone
ofmany resuscitation protocols and liberal use of supplemen-
tal oxygen is common [1]. The negative effects of too much
oxygen are less clear and many health care professionals are
unaware of the possible damage hyperoxemia can cause [2].
In contrast to guidelines describing rational use of drugs,
similar guidelines for optimal use of oxygen are scarce.
However, the British Thoracic Society (BTS) guideline of
2008 [3] does recommend to aim for (near) normal oxygen
saturation for all acutely ill patients and to preclude hyper-
oxemia. Titration of oxygen therapy appears to be feasible,
both in the emergency department (ED) and in the intensive
care unit (ICU) [4, 5]. In critical situations, however, oxygen
supplementation is generally started without checking for
hypoxemia. It is also often not titrated to lower level of
oxygen supplementation, despite oxygen saturation readings
of (close to) 100% or high partial oxygen pressures (PaO
2
)
[6]. Importantly, recent studies have revealed that not only
hypoxemia but also hyperoxemia is associated with increased
mortality, although data are inconsistent [1, 7–9].
Harmful effects of hyperoxemia may be due to various
mechanisms, ranging from vasoconstriction and microvas-
cular blood flow heterogeneity to increased formation of
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reactive oxygen species (ROS) [1, 10]. Oxygen is a critical
element to fuel oxidative phosphorylation for the generation
of ATP by mitochondria. Since ATP is mainly produced by
means of oxidative phosphorylation, hypoxemia may impair
the production of ATP and thereby lead to cellular ATP
depletion. On the other hand, hyperoxemia may also lead
to mitochondrial dysfunction and depletion of cellular ATP
levels. Mitochondria are the major source of ROS, which
are formed by reduction of oxygen in the electron transport
chain (ETC) [11]. Oxidative damage to the ETC-complexes
and inhibition of the citric acid cycle by ROS impedes mito-
chondrial ATP production, which may impair (active) ion
transport and thereby leads to loss of cellular homeostasis [12,
13]. Dysfunction of theNa+/K+-ATPase can initiate cellmem-
brane depolarization and trigger influx of calcium into the
cell through voltage-gated channels [14], which subsequently
leads to calcium influx intomitochondria. Although high lev-
els of calcium in the mitochondrial matrix initially increase
respiratory rate and ATP production [15], a prolonged rise in
calcium within mitochondria induces release of cytochrome
𝑐 and subsequent activation of apoptotic pathways [16]. Taken
together, although hypoxemia may impair the generation of
ATP, hyperoxemia can also lead to depletion of cellular ATP
levels. This is why the standard procedure to supply extra
oxygen may lead to mitochondrial damage by increasing the
formation of ROS [17]. Moreover, hyperoxemia can result
in peripheral vasoconstriction, coronary vasoconstriction,
and a decrease in cardiac output [18]. Thus both molecular
and physiological effects of (high levels of) oxygen may
counteract the positive effects of oxygen supplementation.
Recently, we performed a prospective study in 83 sponta-
neously breathing patients in the ED to evaluate the effect of
conservative oxygen supplementation on blood oxygenation
in sepsis.We demonstrated that reducing the inspired oxygen
fraction (FiO
2
) from 0.6–0.8 to 0.4 precludes hypoxemia
(PaO2 < 9.5 kPa, 9.4 kPa) in 93% of the patients, while 64%
are still hyperoxemic (PaO2 > 13.5 kPa, 13.4 kPa) [19]. So even
lower levels of oxygen supplementation than prescribed lead
to hyperoxemia in the majority of patients. Oxygen is a vital
and potentially life-saving element in emergency care, which
has led to widespread and liberal oxygen supplementation.
But it is important to realize that hyperoxemia is associated
with increased mortality and unfavorable outcome, such
as more neurological impairment and Acute Respiratory
Distress Syndrome (ARDS). Decisions about the initiation
and discontinuation of oxygen supplementation in acutely ill
patients are made in the ED. However, the optimal and non-
toxic level of oxygen supplementation in acutely ill patients
is not clear. To this end, we performed a systematic review
to assess the association between hyperoxemia in acutely
ill patients in the ED and outcome in terms of increased
morbidity and mortality.
2. Methods
2.1. Search Strategy. We performed a systematic review and
searched in databases Medline (PubMed) and Embase on the
following terms: hyperoxemia OR hyperoxemia OR [“oxygen
inhalation therapy” AND (mortality OR death OR outcome
OR survival)] OR [oxygen AND (mortality OR death OR
outcome OR survival)]. We searched for studies performed
in humans, with full text in English or Dutch available (since
these are the languages we are able to read) and that are
published in the last 10 years.This 10-year limitation was cho-
sen because of the new insights into hyperoxia. All abstracts
were read (TS); if the abstract met an exclusion criterion,
the corresponding article was ruled out. This was confirmed
by another author (JL). Of the remaining articles, the entire
text was read (TS, JL). Of the articles that were included in
this way, reference lists were checked for additional relevant
publications, which could also be included if they agreed
with inclusion and exclusion criteria. This resulted in 8 more
suitable articles for inclusion (Figure 1).
2.2. Inclusion and Exclusion Criteria. Original studies about
the clinical effects of hyperoxemia in adult patients suf-
fering from acute or emergency illnesses were included.
Thereby, articles not based on original data (e.g., reviews
and comments on previous articles of expert opinion) were
not included in the review. We excluded articles (1) not
concerning acute conditions and (2) not including clinically
relevant effects (e.g., effects on cell level). Most articles
could be ruled out by reading the title and abstract, for
example, studies performed after birth in neonates, in healthy
volunteers, or in the diving industry. Also papers in patients
with chronic conditions and about use of hyperbaric oxygen
therapy were excluded (Figure 1).
2.3. Data Extraction and Analysis. The entire text of all
included articles was read and its study design, sample size,
definition of hyperoxemia, condition of the patients included,
the location of the study, and its main conclusions were sum-
marized in a tabular fashion. Thereby a comprehensive data
summary of all included articles wasmade, which allowed for
careful analysis and a comprehensive review of the literature.
Differences in study design, heterogeneity, and the different
definitions of hyperoxemia and primary outcomes employed
in the identified studies lead to a relatively high risk of
bias, as assessed using the Cochrane Collaboration’s tool.The
profound risk of bias hampers performing a meta-analysis.
We did not confirm with the authors of the articles that we
used. No review protocol exists.
3. Results
Our literature search identified 35manuscripts describing the
association between hyperoxemia and clinically relevant out-
comes in acutely ill patients. The most important outcomes
are mortality, in-hospital mortality, survival, neurological
outcome, and organ function. Of the 35 articles, 31 could
be divided into four large groups: cardiac arrest, stroke,
traumatic brain injury (TBI), and sepsis (Tables 1, 2, and 3).
These studies are comprised of four randomized controlled
trials (RCT), nine prospective observational studies, and 24
retrospective observational studies. Three other studies were
performed in ventilated patients in the ICU, of which 1
study was a RCT. There was one article about patients with
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Records identiﬁed trough
database searching
n = 1175 (99,3%)
Additional records identiﬁed 
through other sources
n = 8 (0,7%)
Records screened
n = 1183 (100%)
Full-text articles assessed for 
eligibility
n = 64 (5,4%)
Studies included in review
n = 35 (3%)
Records excluded
n = 1119 (94,6%)
Reasons:
(i) Reply on previous article: 33
(2,9%)
(ii) Neonatal studies: 171 (15,3%)
(iii) Diving industry studies:: 15
(1,3%)
(iv) Not about emergency conditions: 
550 (49,2%)
(v) Endpoint not about eﬀects of 
hyperoxia: 287 (25,6%)
(vi) Animal study: 8 (0,7%)
(vii) Hyperbaric oxygen: 55 (4,9%)
Full-text articles excluded
n = 29 (2,4%)
Reasons:
(i) Opinion piece n = 22 (75,8%)
(ii) Not available in Dutch/English 
n = 7 (24,1%)
Figure 1: Search results.
a ST-elevatedmyocardial infarction (STEMI).This articlewill
be discussed first.
Ranchord et al. found no benefit or harm from high-
concentration oxygen therapy versus oxygen therapy titrated
to normoxia in patients with a STEMI 6 hours after pre-
sentation on mortality or infarct size measured by troponin
levels [20]. This study was a randomized study performed in
136 patients. Unfortunately the authors do not mention the
achieved oxygen values in both groups.
3.1. ICU Patients. In one large single-center RCT among
480 ICU patients [50], subjects were randomized either to
conservative oxygen supplementation (PaO
2
70–100mmHg
or oxygen saturations 94–98%) or to conventional oxygen
supplementation (PaO
2
100–150mmHg or oxygen satura-
tions 97–100%). Patients in the conservative group had lower
mortality rates, despite early termination of the study due to
lower than expected inclusion rates. Eastwood et al. (2012)
performed a retrospective cohort study in 152.680 mechan-
ically ventilated patients in 150 ICUs [7]; 49.8% had hyper-
oxia (PaO
2
> 16 kPa). An association was found between
hypoxia and increased in-hospital mortality, but not between
hyperoxia in the first 24 hours and mortality. Another retro-
spective cohort study performed in mechanically ventilated
ICU patients did show an increase in mortality in case of
hyperoxia and also in case of hypoxia [9]. In the three ICU
studies mentioned in this section, patients formed a hetero-
geneous group, since they were suffering from all types of
diseases.
3.2. Cardiac Arrest. Thirteen studies evaluated the potential
negative effects of hyperoxemia on neurological outcome
and mortality in patients after cardiac arrest, as summa-
rized in Table 1. Hyperoxemia during out-of-hospital car-
diopulmonary resuscitation (CPR), measured by point-of-
care analysis in the emergency response car, was associated
with increased hospital admission rates, as demonstrated in
a retrospective cohort study of 1015 patients. No difference in
neurologically intact survival was found related to the oxygen
concentration, however [21]. Furthermore, the occurrence of
hyperoxemia during the first 24 hours of ICU stay in survivors
of cardiac arrest is not associated with poorer neurological
outcome or increasedmortality as compared to normoxemia,
as demonstrated in a prospective observational cohort study
including 409 patients with 12-month follow-up [22]. Similar
to this, no association between the occurrence of hyperox-
emia during the first 24 hours after cardiac arrest and in-
hospital mortality could be demonstrated in a retrospective
cohort study in 584 patients after out-of-hospital cardiac
arrest (OHCA) due to ventricular fibrillation (VF) [23], in a
retrospective cohort study in 5,258 ICU patients after OHCA
[24] and in a larger retrospective cohort study comprising
12,108 patients after cardiac arrest [25]. Hence, different
prospective and retrospective observational cohort studies
were not able to reveal an association between hyperoxemia
during CPR or the first 24 hours after cardiac arrest and poor
outcome.
In contrast to these findings, one retrospective cohort
study found that early hyperoxemia (during the first 60
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Table 1: Association between hyperoxemia and clinically relevant outcomes after myocardial infarction and cardiac arrest.
Reference Study design Samplesize
Hyperoxemia
definition Condition Location Conclusion
[20], Ranchordet al. RCT 136 6 LO
2
/min STEMI - High-O2 therapy had no effect onmortality or infarct size
[21], Spindelboeck et al. Retrospectivecohort 1015 PaO2 > 40.0 kPa Cardiac arrest Pre-hospital
Higher hospital admission rates when
during CPR
[22], Vaahersalo et al. Prospectivecohort 409 PaO2 > 40.0 kPa Cardiac arrest ICU
No association with different 12
month outcome
[23], Ihle et al. Retrospectivecohort 584 PaO2 > 40.0 kPa Cardiac arrest ICU
No association with in-hospital
mortality
[24], Helmerhorst et al. Retrospectivecohort 5258 PaO2 > 39.9 kPa Cardiac arrest ICU
Hyperoxia not associated with higher
mortality rates
[25], Bellomo et al. Retrospectivecohort 12,108 PaO2 > 40.0 kPa Cardiac arrest ICU No association with mortality
[26], Chirst et al. Retrospectivecohort 134 - Cardiac arrest -
Hyperoxia in the first 60 minutes after
return of circulation is associated with
better survival rates
[27], Lee et al. Retrospectivecohort 213 - Cardiac arrest -
Hypocarbia associated with
in-hospital mortality. Hypoxemia and
hyperoxemia associated with poor
neurological outcome.
[28], Kilgannon et al. Retrospectivecohort 6,326 PaO2 > 40.0 kPa Cardiac arrest ICU
Higher mortality rates, even when
compared to hypoxemia
















Severe associated with higher
in-hospital mortality.
Moderate/probable was not but was
associated with improved organ
function after 24 hours.
[30], Kilgannon et al. Retrospectivecohort 4,459 - Cardiac arrest ICU
Dose-dependent association with
in-hospital mortality





170 - Cardiac arrest Cardiovascularcare unit
Higher in-hospital mortality and poor
neurological status on hospital
discharge in survivors
[32], Young et al. RCT 18 - Cardiac arrest Prehospital
Study terminated early, because
pre-hospital oxygen titration was not
feasible.
minutes after return of spontaneously circulation) in patients
with OHCA was associated with better survival rates [26].
Yet in another study both hyperoxemia and hypoxemia are
associated with poor neurological outcome, although no
influence of hyperoxemia on in-hospital mortality was found
[27]. And another retrospective cohort study comprising
6,326 patients after cardiac arrest reveals an independent
association between hyperoxemia and higher in-hospital
mortality rates, as compared to normoxemia and hypoxemia
[28]. In particular, severe hyperoxemia, which is defined as
PaO
2
> 39.9 kPa, seems to be independently associated with
increased in-hospital mortality [29]. Moreover, a multicenter
study including 4,459 patients after cardiac arrest revealed a
linear, dose-dependent association between oxygen and in-
hospital mortality: a 13.3 kPa increase in PaO
2
was associated
with a 24% increase in mortality risk [30]. The occurrence
of hyperoxemia during postresuscitation care combined
with mild hypothermia is independently associated poorer
neurological outcome at hospital discharge and increased
in-hospital mortality, as demonstrated in an observational
cohort study comprising 170 patients. As such, survivors
(45%) had a lower maximum PaO
2
(26.4 kPa) in the first 24
hours versus nonsurvivors (55%; 33.9 kPa) [31]. So in contrast
to the lack of an association between (mild) hyperoxemia
during the early stages after cardiac arrest and neurologically
intact survival, severe hyperoxemia and hyperoxemia during
postresuscitation care seem to be associated with poorer
outcome.
Current evidence describing the advantages and draw-
backs of hyperoxemia during and after CPR is limited to
observational studies. Unfortunately, a randomized multi-
center single-blind trial (HOT or NOT, 2014), in which the
goal was to assess the prehospital effect of oxygen titration
versus standard oxygen therapy after out-of-hospital cardiac
BioMed Research International 5
Table 2: Association between hyperoxemia and clinically relevant outcomes after stroke and traumatic brain injury.
Reference Study design Samplesize
Hyperoxemia
definition Condition Location Conclusion
[33], Young et al. Retrospectivecohort 2,643 - Ischaemic stroke ICU No association with mortality.







Associated with higher in-hospital
mortality, also when compared to
hypoxemia.






, but higher PaO
2
levels after multivariate analysis not
associated with unfavorable
outcome or mortality





16 O2 45 L/min, 8hours Ischaemic stroke -
Transient improvement of clinical
deficits and MRI abnormalities after
24 hours





40 O2 10 L/min, 12hours Ischaemic stroke -
No improvement in functional or
neurological outcome after 3
months
[38], Nortje et al. Prospectivecohort 11 FiO2 35–50% TBI - Increases brain tissue oxygenation.





[40], Vilalta et al. Prospectivecohort 30 FiO2 100% TBI ICU
Improves brain redox state in
patients with initially elevated brain
lactate levels
[41], Diringer et al. Prospectivecohort 5 FiO2 100% TBI
Neurosurgical
ICU
No improvement on brain
metabolism.
[42], Puccio et al. Prospectivecohort 11 FiO2 100% TBI
Neurotrauma
ICU
Brief periods do not produce
oxidative stress and/or change
antioxidant reserves in
cerebrospinal fluid.
[43], Davis et al. Retrospectivecohort 3,420 PaO2 > 64.9 kPa TBI -
Independently associated with
increased mortality and decrease in
good outcomes.
[44], Rincon et al. Retrospectivecohort 1,212 PaO2 > 40.0 kPa TBI ICU
Independently associated with
higher in-hospital mortality.
[45], Asher et al. Retrospectivecohort 193 PaO2 > 64.8 kPa TBI - Decrease in survival
[46], Raj et al. Retrospectivecohort 1,116 PaO2 > 13.3 kPa TBI ICU No effect on 6 month mortality
arrest, was terminated early because titration of oxygen
in the prehospital period following OHCA appeared to
be unfeasible. The authors suggested that it may be more
practicable to titrate the dosage of oxygen down immediately
after arrival at the ED or elsewhere in hospital [32]. In
conclusion, the level of evidence describing the effect of
hyperoxemia on clinically relevant outcome after cardiac
arrest is low. Outcomes of studies evaluating hyperoxemia
after cardiac arrest are unequivocal, although current data
suggests an association between (severe) hyperoxemia during
postresuscitation care and lower levels of intact neurological
survival.
3.3. Stroke. The use of hyperoxemia in acute neurological
events is controversial. While some state that it has beneficial
effects on the injured brain and should be used as therapy
due to its hemodynamic effects, others state that hyperoxemia
should be avoided as it may increase neurological damage
due to the formation of ROS. We included five studies in
patientswith stroke (Table 2).The application of hyperoxemia
in ventilated patients early after acute ischemic stroke is
not associated with poor functional outcome or increased
mortality, as revealed in a retrospective study in 2,643 patients
[33]. In contrast, a retrospective multicenter study in 2,894
ventilated patients after acute ischemic stroke, subarachnoid
6 BioMed Research International
Table 3: Association between hyperoxemia and clinically relevant outcomes in sepsis.
Reference Study design Samplesize
Hyperoxemia
definition Condition Location Conclusion
[19], Stolmeijer et al. Prospectivecohort 83 PaO2 > 13.5 kPa Sepsis ED
More than 64% of patients were




[47], Rossi et al. Prospectivecohort 14 FiO2 100% Sepsis ICU
Decreases oxygen delivery in upper
limbs.







Sepsis ED Associated with increased mortality.
[49], Dahl et al. Retrospectivecohort 1,770 PaO2 > 16.0 kPa Sepsis ICU





hemorrhage (SAH), and intracerebral hemorrhage demon-
strated an independent association between hyperoxemia
and increased in-hospital mortality. This was 60% after
hyperoxemia and 47% after normoxemia [34]. The effect of
hyperoxemia on neurological outcome was not assessed in
this study unfortunately. Another retrospective cohort study
in mechanically ventilated patients with a SAH in the ICU
showed that patients with unfavorable outcome (Glasgow
Coma Score 1–3) had significantly higher PaO
2
levels. But
in a multivariate regression analysis no association between
PaO
2
and unfavorable outcome of mortality was found
[35]. A small randomized and partially blinded pilot study
in which patients were treated with high levels of oxygen
supplementation (45 L/min for 8 hours) or ambient air after
acute ischemic stroke revealed a transient improvement of
clinical deficits and MRI abnormalities at 24 hours after
inclusion. This disappeared at three-month follow-up [36].
In this study the effect of hyperoxemia on mortality was
not assessed. Another randomized study where 40 patients
with acute ischemic stroke received either high oxygen
supplementation (10 L/min for 12 hours) or ambient air was
not able to demonstrate an association between high oxygen
supplementation and neurological or functional outcome
during three-month follow-up [37]. In summary, the associa-
tion between hyperoxemia after stroke has been described in
a very low number of studies, who either describe no effect
of hyperoxemia on clinically relevant outcomes or suggest
minor transient protective effects of hyperoxemia.
3.4. Traumatic Brain Injury. Hyperoxemia may have pro-
tective effects after TBI by improving brain oxygenation
and thereby preventing ischemic injury. The application of
hyperoxemia after TBI improves brain tissue oxygenation
indeed, as demonstrated by cerebral microdialysis, brain tis-
sue oximetry, and oxygen-15 positron emission tomography
(PET) in a small study comprising 11 patients with TBI [38].
The use of hyperoxemia not only increases brain oxygen
levels, but subsequently also leads to a reduced lactate-
pyruvate ratio, which suggests an improved preservation of
mitochondrial respiration [39, 40]. Despite an improvement
in brain oxygenation and metabolism after TBI, a smaller
study comprising five patients with TBI demonstrated no
effects on arterial blood pressure, intracranial pressure, and
cerebral blood flow when patients were subjected to a FiO2
of 0.3–0.5 or 1.0 for one hour [41]. Moreover, the use of
hyperoxemia in TBI patients is not associated with increased
levels of oxidative stress or changes in antioxidant reserves
in spinal fluid [42]. Hence, hyperoxemia is associated with
improved oxygenation and better mitochondrial respiration
after TBI.
The occurrence of hyperoxemia after severe TBI is asso-
ciated with a decrease in good clinical outcome (such as
being able to be discharged home) and higher levels of
mortality, as demonstrated in a registry based retrospective
cohort comprising 3,420 patients with severe TBI [43].
Similar findings were obtained in a multicenter retrospective
registry study among 1,212 mechanically ventilated patients
suffering from TBI, where hyperoxemia within 24 hours
after admission to the ICU is independently associated with
higher in-hospital mortality rates [44]. These findings are in
line with a small retrospective cohort study, demonstrating
increased mortality among patients with either hypoxemia
(PaO
2
< 33.3 kPa) and hyperoxemia (PaO
2
> 64.8 kPa) as
compared to normoxemia after TBI [45]. Another relatively
large retrospective cohort study, comprising 1,116 patients
with TBI, was not able to reveal an association between
hyperoxemia (> 13.3 kPa) and mortality at six-month follow-
up in contrast [46]. In conclusion, although hyperoxemia
after TBI improves brain oxygenation and mitochondrial
function, the use of hyperoxemia seems to be associated with
increased in-hospital mortality.
3.5. Sepsis. In contrast to cardiac arrest, stroke, and TBI,
optimizing cellular oxygen delivery may be even more dif-
ficult in patients with sepsis, which is characterized by a
reduced cellular oxygen extraction from the circulation.This
phenomenon called “cytopathic hypoxia” is reflected in the
relatively high venous oxygen level as compared to the arterial
oxygen level and is likely due to mitochondrial dysfunction
[51–53]. Mitochondrial dysfunction is an early and important
event that may progress into loss of cellular homeostasis,
organ failure, and ultimately death of the patient [54, 55].The
induction of brief hyperoxemia, by increasing the FiO
2
to 1.0
for 20 minutes in ventilated patients with severe sepsis and
BioMed Research International 7
septic shock, paradoxically even decreases oxygen delivery
in the upper limbs [47]. High central venous oxygen levels
(ScvO
2
; 90–100%) are associated with increased mortality
rates, as demonstrated in a prospective study comprising 619
septic patients treated with early goal-directed therapy in the
ED [48]. It should be noted, however, that the ScvO
2
during
sepsis is not only influenced by the level of oxygen supple-
mentation, but also by the occurrence of cytopathic hypoxia,
which leads to a rise in ScvO
2
. Therefore, arterial oxygen
levels better reflect the effect of oxygen supplementation
in sepsis. High levels of oxygen supplementation (reflected
by FiO
2
> 60%) and also hypoxemia (PaO
2
< 8 kPa) are
associated with higher in-hospital mortality rates among
1,770 patients with severe sepsis or septic shock admitted to
the ICU [49].
4. Discussion
Despite the longstanding and ubiquitous use of oxygen there
is a paucity of data regarding its optimal use. Remarkably,
guidelines describing the optimal dose of oxygen to be
supplemented are scarce and current evidence is largely of
low level, since it is largely based on observational cohort
studies. There are only a few randomized prospective studies
describing the effects of hyperoxemia on clinically relevant
outcomes. Although we aimed to review the described
effects of hyperoxemia on clinically relevant outcomes among
acutely ill patients at the ED, most studies describe the effects
of hyperoxemia after cardiac arrest, stroke, TBI, or sepsis
among patients admitted to the ICU. However, since most
patients presenting with these conditions will be primarily
admitted to the ED before going to the ICU, we feel that
these presented findings can also be applied to these spe-
cific ED populations. Yet it remains to be studied whether
a similar association between hyperoxemia and clinically
relevant outcomes (such as neurological or functional status
and mortality) also applies to the patients at the ED that
will not be admitted to the ICU. Investigating the potentially
negative effects of hyperoxemia in this population may be
of major clinical relevance, since oxygen treatment is mostly
initiated in the ambulance and continued or started in the
ED. There is the need for, preferably randomized, trials with
well-defined outcome parameters, including neurological
outcome, quality of life, and mortality, to achieve a higher
level of evidence.
5. Conclusion
Despite the widespread and liberal use of oxygen supple-
mentation in patients with acute illness, which is expected
to lead to hyperoxemia in the majority of patients, stud-
ies describing the association between hyperoxemia and
clinically relevant outcomes are scarce. Although a single
study suggested transient improvement of clinical deficits
after ischemic stroke treated with high oxygen supplemen-
tation, all other studies reviewed here revealed no positive
association between hyperoxemia and outcome (such as
neurological or functional recovery and mortality). Impor-
tantly, several studies described a clear association between
hyperoxemia and increased mortality after cardiac arrest,
stroke, and TBI. The association between hyperoxemia in
sepsis and outcome remains to be studied. Despite these
uncertainties, measuring blood oxygenation and aiming for
normoxemia may potentially lower the morbidity and mor-
tality associated with hyperoxemia. There is some support
that the old paradigmbyParacelsus that toxicity only depends




ICU: Intensive care unit
MRI: Magnetic resonance imaging
NRM: Nonrebreathing mask
OHCA: Out-of-hospital cardiac arrest
PaO
2
: Partial pressure of oxygen in arterial blood
ROS: Reactive oxygen species
ROSC: Return of spontaneous circulation
ScvO
2
: Central venous oxygen saturation
STEMI: ST-segment elevation myocardial
infarction




Strengths of This Study. A comprehensive review about the
association between hyperoxemia and clinically relevant
outcomes in acutely ill adult patients. Limitations of This
Study.Most reviewed studies are of a low level of evidence and
mostly performed amongpatients admitted to the ICU,which
does not cover the entire spectrum of emergency medicine.
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